Cidara Therapeutics, Inc. revenue for the last year amounted to 63.91 M USD, the most of which — 63.91 M USD — came from its highest performing source at the moment, Antifungal and Antiviral Drugs, the year earlier bringing 64.29 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Cidara Therapeutics, Inc. 63.91 M USD, and the year before that — 64.29 M USD.